Illumina divestment for GRAIL buy worth the wait, says Canaccord

Canaccord analyst Kyle Mikson noted the European Commission sent a Statement of Objections to Illumina and GRAIL informing them of the restorative measures it intends to adopt under the European Union merger regulation and establishing the divestment measures it believes Illumina must implement to unwind the GRAIL transaction. he said a separation appears to be in the best interest of both companies and positive for ILMN shares, recognizing that timing remains uncertain. Mikson maintained his Buy rating and $330 price target on Illumina shares.